Rita Assi

1.7k total citations
49 papers, 824 citations indexed

About

Rita Assi is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Rita Assi has authored 49 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 17 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Rita Assi's work include Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). Rita Assi is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). Rita Assi collaborates with scholars based in United States, Lebanon and Japan. Rita Assi's co-authors include Hagop M. Kantarjian, Farhad Ravandi, Jörge E. Cortes, Naval Daver, Guillermo Garcia‐Manero, Ali Shamseddine, Tapan M. Kadia, Elias Jabbour, Koichi Takahashi and Courtney D. DiNardo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rita Assi

45 papers receiving 809 citations

Peers

Countries citing papers authored by Rita Assi

Since Specialization

Citations

This map shows the geographic impact of Rita Assi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Assi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Assi more than expected).

Fields of papers citing papers by Rita Assi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Assi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Assi. The network helps show where Rita Assi may publish in the future.

Co-authorship network of co-authors of Rita Assi

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Assi. A scholar is included among the top collaborators of Rita Assi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Assi. Rita Assi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation 2023 ·Transplantation and Cellular Therapy ·(unknown), Qing Cao, Mark Juckett, Brian C. Betts, Shernan G. Holtan, Najla El Jurdi, Marie Hu, (unknown), Rita Assi, Joseph Maakaron	7
2	Diagnostic Yield of Endobronchial Ultrasound–Guided Mediastinal Lymph Node Transbronchial Forceps Biopsies (EBUS-TBFB) 2023 ·Southern Medical Journal ·Khalil Diab, Christy Costanian, (unknown), (unknown), (unknown), (unknown), Chen Zhang, Rita Assi	0
3	Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare? 2022 ·Cells ·Rita Assi, Huda Salman	3
4	Unplanned adnexectomy for ovarian cystadenoma with undiagnosed autoamputation of the contralateral ovary, lessons learned from medical mistakes 2021 ·Facts Views and Vision in ObGyn ·(unknown), (unknown), Rita Assi, Zaki Sleiman	2
5	The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia 2020 ·Leukemia ·Mansour Alfayez, Ghayas C. Issa, Keyur P. Patel, Feng Wang, Xuemei Wang, Nicholas J. Short, Jörge E. Cortes, Tapan M. Kadia, Farhad Ravandi, Sherry Pierce, Rita Assi, Guillermo Garcia‐Manero, Courtney D. DiNardo, Naval Daver, Naveen Pemmaraju, Hagop M. Kantarjian, Gautam Borthakur	43
6	Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia 2019 ·Cancer ·Christopher B. Benton, Prajwal Boddu, Courtney D. DiNardo, Prithviraj Bose, (unknown), Rita Assi, Naveen Pemmaraju, (unknown), Sherry Pierce, Keyur P. Patel, Marina Konopleva, Farhad Ravandi, Guillermo Garcia‐Manero, Tapan M. Kadia, Jörge E. Cortes, Hagop M. Kantarjian, Michael Andreeff, Srđan Verstovšek	27
7	Final results of a phase 2, open‐label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome 2018 ·Cancer ·Rita Assi, Hagop M. Kantarjian, Tapan M. Kadia, Naveen Pemmaraju, Elias Jabbour, Nitin Jain, Naval Daver, Zeev Estrov, Taisuke Uehara, Takashi Owa, Jörge E. Cortes, Gautam Borthakur	82
8	Safety and Efficacy of Blinatumomab in Patients with Central Nervous System (CNS) Disease: A Single Institution Experience 2018 ·Blood ·Mansour Alfayez, Hagop M. Kantarjian, Nicholas J. Short, Rita Assi, Maria Khouri, Farhad Ravandi, Shilpa Paul, Caitlin R. Rausch, (unknown), Gautam Borthakur, Courtney D. DiNardo, Tapan M. Kadia, Naval Daver, Guillermo Garcia‐Manero, Kiran Naqvi, Prithviraj Bose, Susan O’Brien, Jörge E. Cortes, Elias Jabbour	11
9	Reduced Contrast Volume and Radiation Dose During Computed Tomography of the Pancreas 2018 ·Academic Radiology ·Charbel Saade, (unknown), Lena Naffaa, Walid Faraj, Ali Shamseddine, Deborah Mukherji, Skye El Sayegh, Rita Assi, Ali Haydar	2
10	Management of Chronic Myeloid Leukemia (CML) during Pregnancy Among Patients (pts) Treated with a Tyrosine Kinase Inhibitor (TKI): A Single-Center Experience 2017 ·Blood ·Rita Assi, Hagop M. Kantarjian, Michael J. Keating, Naveen Pemmaraju, Srđan Verstovšek, Guillermo Garcia‐Manero, Farhad Ravandi, Gautam Borthakur, (unknown), Elias Jabbour, Jörge E. Cortes	3
11	The Combination of Ruxolitinib (RUX) with Decitabine (DAC) in Patients (Pts) with Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML): Interim Report of a Phase I/II Trial 2017 ·Blood ·Rita Assi, Prithviraj Bose, Srđan Verstovšek, Yvonne Gasior, Nitin Jain, Elias Jabbour, Zeev Estrov, Yesid Alvarado, Courtney D. DiNardo, Naveen Pemmaraju, Steven M. Kornblau, Tapan M. Kadia, Naval Daver, Mark Brandt, Sherry Pierce, Xuelin Huang, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Farhad Ravandi	2
12	JAK3 Variants in Adults with Myeloid Malignancies and Potential for Response to JAK3 Inhibition 2017 ·Blood ·Rita Assi, Christopher B. Benton, (unknown), Kamal Chamoun, (unknown), Sherry Pierce, Keyur P. Patel, Betty K. Hamilton, Courtney D. DiNardo, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Tapan M. Kadia, Srđan Verstovšek, Michael Andreeff	1
13	‘JAK–ing’ up the treatment of primary myelofibrosis: building better combination strategies 2017 ·Current Opinion in Hematology ·Rita Assi, Srđan Verstovšek, Naval Daver	7
14	Recent Progress in Mutation-driven Therapy, Immunotherapy and Combination Therapy for the Treatment of Melanoma 2017 ·Current Cancer Drug Targets ·Hazem Assi, Rita Assi	1
15	Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors 2017 ·Current Opinion in Hematology ·Rita Assi, Hagop M. Kantarjian, Farhad Ravandi, Naval Daver	62
16	Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Rita Assi, Hagop M. Kantarjian, Nicholas J. Short, Naval Daver, Koichi Takahashi, Guillermo Garcia‐Manero, Courtney D. DiNardo, Jan A. Burger, Jörge E. Cortes, Nitin Jain, William G. Wierda, (unknown), Marina Konopleva, Elias Jabbour	116
17	An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses 2017 ·Journal of Gastrointestinal Oncology ·Neil Vasan, Maria Ignez Braghiroli, Alexander N. Shoushtari, Richard Kinh Gian, Marcia Edelweiss, Ali Shamseddine, Walid Faraj, Deborah Mukherji, Ali Haydar, (unknown), (unknown), Rita Assi, Imane El Dika, Leonard B. Saltz, Ghassan K. Abou‐Alfa, Eileen M. O’Reilly	1
18	New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer 2016 ·Current Drug Targets ·Rita Assi, Sally Temraz, Ali Shamseddine, Deborah Mukherji	0
19	Hemophagocytic lymphohistiocytosis in adults: An under recognized entity 2016 ·PubMed ·(unknown), Tariq Muzzafar, Rita Assi, Dawid Schellingerhout, Zeev Estrov, Gevorg Tamamyan, Hagop M. Kantarjian, Naval Daver	11
20	The role of 68Ga-DOTA-NOC PET/CT in evaluating neuroendocrine tumors 2016 ·Nuclear Medicine Communications ·Mohamad Haidar, Ali Shamseddine, Emmanouil Panagiotidis, Mario Jreige, Deborah Mukherji, Rita Assi, (unknown), Toni Ibrahim, M. Haddad, Sobhan Vinjamuri	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact